Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/20520601
Conclusion of this study
Placebo administration in MH participants decreased alertness and increased headache. Caffeine did not increase alertness in NL participants. With frequent consumption, substantial tolerance develops to the anxiogenic effect of caffeine, even in genetically susceptible individuals, but no net benefit for alertness is gained, as caffeine abstinence reduces alertness and consumption merely returns it to baseline.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study